Methotrexate for psoriasis in weekly oral doses.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000740:Anemia / Q000139:chemically induced; D001219:Aspartate Aminotransferases / Q000097:blood; D002648:Child; D005260:Female; D005493:Folic Acid Antagonists / Q000378:metabolism; D005500:Follow-Up Studies; D006801:Humans; D007677:Kidney Function Tests; D007970:Leukopenia / Q000139:chemically induced; D008111:Liver Function Tests; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced
D005493:Folic Acid Antagonists; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D008727:Methotrexate